EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses

Wenjie Qiao iD, Xuping Xie iD, Pei-Yong Shi, Yaw Shin Ooi iD, Jan E Carette iD

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2421573122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Wenjie Qiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305. Hauptthemen laut MEDLINE: Antiviral Agents, Flavivirus, Flavivirus Infections, Aspartic Acid Endopeptidases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NIAID NIH HHS, SU | SOM | Stanford Maternal and Child Health Research Institute (MCHRI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mosquito-borne flaviviruses, such as dengue virus (DENV), Zika virus (ZIKV), West Nile virus, and yellow fever virus, pose significant public health threats globally. Extensive efforts have led to the development of promising highly active compounds against DENV targeting viral non-structural protein 4B (NS4B) protein. However, due to the cocirculation of flaviviruses and to prepare for emerging flaviviruses, there is a need for more broadly acting antivirals. Host-directed therapy where one targets a host factor required for viral replication may be active against multiple viruses that use similar replication strategies. Here, we used a CRISPR-Cas9 library that we designed to target the druggable genome and identified signal peptide peptidase (SPP, encoded by Histocompatibility Minor 13, HM13), as a critical host factor in DENV infection. Genetic knockout or introducing mutations that disrupt the proteolytic activity of SPP markedly reduced the replication of multiple flaviviruses. Although their substrates differ, SPP has structural homology with γ-secretase, which has been pursued as a pharmacological target for Alzheimer’s disease. Notably, SPP-targeting compounds exhibited potent anti-DENV activity at low nanomolar concentrations across multiple primary and disease-relevant cell types, acting specifically through SPP inhibition rather than γ-secretase inhibition. Importantly, SPP inhibitors were active at low nanomolar concentrations against flaviviruses other than DENV including ZIKV while DENV NS4B inhibitors lost activity. This study emphasizes the strong potential of SPP as a pan-flaviviral target and provides a framework for identifying host druggable targets to screen for broad-spectrum antivirals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsFlavivirusFlavivirus InfectionsAspartic Acid EndopeptidasesHumansVirus ReplicationCRISPR-Cas SystemsZika VirusAnimalsDengue VirusWest Nile virusHEK293 Cells

Stichwörter der Autor:innen

CRISPR screensdruggable genomeflavivirushost-directed antiviralsignal peptide peptidase (SPP/HM13)

Substanzen

Antiviral AgentsAspartic Acid Endopeptidases

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305.
  • Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
  • Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.
  • Program in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
  • Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore 138648, Singapore.

ORCID-Profile: Wenjie Qiao, Xuping Xie, Yaw Shin Ooi, Jan E Carette

Förderung

  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIAID NIH HHS
  • SU | SOM | Stanford Maternal and Child Health Research Institute (MCHRI)
  • Burroughs Wellcome Fund (BWF)
  • SU | School of Medicine, Stanford University (SOM)

Zitieren

APA

Qiao, W., Xie, X., Shi, P. Y., Ooi, Y. S., & Carette, J. E. (2025). Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2421573122

Vancouver

Qiao W, Xie X, Shi PY, Ooi YS, Carette JE. Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2421573122

BibTeX
@article{Qiao2025,
  author = {Qiao, Wenjie and Xie, Xuping and Shi, Pei-Yong and Ooi, Yaw Shin and Carette, Jan E},
  title = {Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2421573122}
}
Kostenlos starten →